Screen and Design p18 Chemical Probes for Hematopoietic Stem Cell Self-Renewal

用于造血干细胞自我更新的 p18 化学探针的筛选和设计

基本信息

  • 批准号:
    8284383
  • 负责人:
  • 金额:
    $ 18.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

Human hematopoietic stem cells (HSC) transplantation is currently being used as regenerative medicine for the treatment of congenital deficiencies and malignant diseases as well as cancers and other disorders of the blood and immune systems. However, despite all the enthusiasm surrounding HSC biology and therapeutics, the potential of HSC-based therapies has yet to be fully realized. A major roadblock of broader use of the adult stem cells is the limited number of HSC per harvest for therapeutic benefit and their poorly understood expansion and differentiation behavior in response to proliferative stimuli. In vitro expansion of HSC remains a major challenge for wide applications of HSC transplantation for patients. Our studies show that p18, a member of the cyclin-dependent kinase (CDK) inhibitors (CKI), is a potent negative regulator of HSC self- renewal. Thus, we hypothesize that p18 is a unique drug target, and that small molecules capable of blocking p18 function and interfering with p18/CDK6 interactions are likely to be potent drugs for activating HSC self- renewal. Our objective is to screen/identify p18 inhibitors that act by disrupting p18/CDK6 interactions, thus activating HSC self-renewal and increasing the quantity of active stem cells, and to use them as chemical probes for mechanism studies of HSC self-renewal. The feasibility of the proposed innovative research is supported by the proof-of-principle pilot data obtained by well-established research teams that have complementary expertise for the proposed research. Considering the limited throughput capacity of the current HSC bone-marrow culture protocol, we propose first to use our established in silico screening approach for initial screening to generate p18-focused lead sublibraries (Aim 1). We also apply NMR assays to screen/validate and characterize the p18 hits and their binding interactions with the protein in order to generate p18-active subsets (Aim 2A). Also, the small subsets of validated p18-targeting compounds will then be confirmed by extensive HSC functional assays (Aim 2B). Through these, the compounds that are capable of increasing the number of active stem cells in the bone-marrow culture will be identified as leads. The discovered leads are then used as specific chemical probes for studies of p18/CDK6 interactions and signaling mechanisms of the G1-phase of the cell cycle. As a future plan, the identified leads will be further optimized by chemistry modification and SAR medicinal chemistry studies to improve the potency and cell toxicity. Our long- term goal is to identify/design CKI p18-specific small molecule effectors that can either maintain/stimulate self- renewal of hematopoietic stem cells in a predictable manner, and ultimately to develop new drugs for HSC therapies. Achieving this goal will have a significant impact on stem cell drug research development in general.
人类造血干细胞(HSC)移植目前正被用作再生医学 先天缺陷和恶性疾病以及癌症和其他疾病的治疗 血液和免疫系统。然而,尽管人们对HSC生物学和治疗学充满热情, 基于HSC的治疗的潜力还没有完全实现。成年人更广泛使用的一个主要障碍 干细胞是每一次收获的有限数量的HSC,用于治疗的益处以及它们的知之甚少 对增殖刺激作出反应的扩增和分化行为。HSC的体外扩增仍是一种 造血干细胞移植在患者中广泛应用的主要挑战。我们的研究表明,p18,a 细胞周期蛋白依赖性激酶(CDK)抑制因子(CKI)是HSC自身的一种强有力的负性调节因子。 更新。因此,我们假设p18是一个独特的药物靶点,而能够阻止 P18功能和干扰p18/CDK6相互作用可能是激活HSC自身的强效药物。 更新。我们的目标是筛选/识别通过破坏p18/CDK6相互作用而起作用的p18抑制剂,从而 激活HSC自我更新,增加活跃干细胞数量,并将其用作化学物质 HSC自我更新机制研究的探讨。拟议的创新研究的可行性是 由久负盛名的研究团队获得的原则验证试点数据支持,这些研究团队 为拟议的研究提供补充专业知识。考虑到目前的吞吐能力有限 HSC骨髓培养方案,我们建议首先使用我们已建立的电子筛查方法 初步筛选以产生以p18为中心的铅亚库(目标1)。我们还将核磁共振分析应用于 筛选/验证和表征p18 HITS及其与蛋白质的结合作用,以便生成 P18--活动子集(目标2A)。此外,验证的p18靶向化合物的小子集将是 经广泛的肝星状细胞功能分析确认(目标2B)。通过这些,这些化合物能够 在骨髓培养中增加活跃干细胞的数量将被确定为先导。这个 然后,发现的铅被用作研究p18/CDK6相互作用和信号转导的特定化学探针 细胞周期中G1期的作用机制。作为未来计划,已确定的销售线索将通过 化学修饰和SAR药物化学研究,以提高效力和细胞毒性。我们的长- 学期目标是确定/设计CKI p18特异性小分子效应器,它可以维持/刺激自我 以可预测的方式更新造血干细胞,并最终开发治疗HSC的新药 治疗。实现这一目标将对干细胞药物研究发展产生重大影响。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cancer genomics: opportunities for medicinal chemistry?
癌症基因组学:药物化学的机会?
  • DOI:
    10.4155/fmc.16.1
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Wang,Lirong;Xie,Xiang-Qun
  • 通讯作者:
    Xie,Xiang-Qun
N-terminal arginylation generates a bimodal degron that modulates autophagic proteolysis.
N 端精氨酸化产生双峰降解决定子,调节自噬蛋白水解。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiang-Qun Xie其他文献

Xiang-Qun Xie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiang-Qun Xie', 18)}}的其他基金

SmartAD for Intelligent Alzheimer’s Disease(AD) Personalized Combination Therapy
SmartAD 智能阿尔茨海默病 (AD) 个性化联合治疗
  • 批准号:
    10701069
  • 财政年份:
    2022
  • 资助金额:
    $ 18.74万
  • 项目类别:
SmartAD for Intelligent Alzheimer’s Disease(AD) Personalized Combination Therapy
SmartAD 智能阿尔茨海默病 (AD) 个性化联合治疗
  • 批准号:
    10670481
  • 财政年份:
    2022
  • 资助金额:
    $ 18.74万
  • 项目类别:
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
大麻素 CB2 受体结构和变构调节剂
  • 批准号:
    10297210
  • 财政年份:
    2021
  • 资助金额:
    $ 18.74万
  • 项目类别:
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
大麻素 CB2 受体结构和变构调节剂
  • 批准号:
    10448397
  • 财政年份:
    2021
  • 资助金额:
    $ 18.74万
  • 项目类别:
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
大麻素 CB2 受体结构和变构调节剂
  • 批准号:
    10612431
  • 财政年份:
    2021
  • 资助金额:
    $ 18.74万
  • 项目类别:
Screen and Design p18 Chemical Probes for Hematopoietic Stem Cell Self-Renewal
用于造血干细胞自我更新的 p18 化学探针的筛选和设计
  • 批准号:
    8174548
  • 财政年份:
    2011
  • 资助金额:
    $ 18.74万
  • 项目类别:
CHEMINFORMATICS DATA-MINING FOR MOLECULAR FINGERPRINT CALCULATION
用于分子指纹计算的化学信息学数据挖掘
  • 批准号:
    8364201
  • 财政年份:
    2011
  • 资助金额:
    $ 18.74万
  • 项目类别:
CHEMINFORMATICS DATA-MINING FOR MOLECULAR FINGERPRINT CALCULATION
用于分子指纹计算的化学信息学数据挖掘
  • 批准号:
    8171779
  • 财政年份:
    2010
  • 资助金额:
    $ 18.74万
  • 项目类别:
Structure/Function of the CB2 Receptor Binding and G-protein Recognition Pockets
CB2 受体结合和 G 蛋白识别袋的结构/功能
  • 批准号:
    8248180
  • 财政年份:
    2010
  • 资助金额:
    $ 18.74万
  • 项目类别:
Structure/Function of the CB2 Receptor Binding and G-protein Recognition Pockets
CB2 受体结合和 G 蛋白识别口袋的结构/功能
  • 批准号:
    8851758
  • 财政年份:
    2010
  • 资助金额:
    $ 18.74万
  • 项目类别:

相似国自然基金

greenwashing behavior in China:Basedon an integrated view of reconfiguration of environmental authority and decoupling logic
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金项目

相似海外基金

RUI: CAS-MNP: Molecular Behavior at Colloidal/Aqueous Interfaces of Heterogeneous Nano- and Micro-Plastics - Binding Interactions and Effect of Aging
RUI:CAS-MNP:异质纳米和微米塑料胶体/水界面的分子行为 - 结合相互作用和老化效应
  • 批准号:
    2304814
  • 财政年份:
    2023
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Standard Grant
Synthesis of Liquid-Crystalline Viologen Compounds with Flexible Ion Binding Sites and Their Photo-Responsive Behavior
具有灵活离子结合位点的液晶紫罗碱化合物的合成及其光响应行为
  • 批准号:
    17K14532
  • 财政年份:
    2017
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Identifying Neurosensory Solutions to the Binding Problem in Animal Behavior
确定动物行为中约束问题的神经感觉解决方案
  • 批准号:
    1452831
  • 财政年份:
    2015
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Continuing Grant
Development of cryptand molecules of multiple ligation with allosteric binding behavior
具有变构结合行为的多重连接的穴状配体分子的开发
  • 批准号:
    21550045
  • 财政年份:
    2009
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The biological role of odorant-binding proteins in insect behavior
气味结合蛋白在昆虫行为中的生物学作用
  • 批准号:
    21688003
  • 财政年份:
    2009
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
Control of interfacial behavior through lipid domain formation, ligand-receptor binding and their synergetic effect
通过脂质域形成、配体-受体结合及其协同效应控制界面行为
  • 批准号:
    0828046
  • 财政年份:
    2008
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Continuing Grant
Occurence and Mechanisms of Antibody-Antigen Allosteric Binding Behavior
抗体-抗原变构结合行为的发生和机制
  • 批准号:
    6727039
  • 财政年份:
    2004
  • 资助金额:
    $ 18.74万
  • 项目类别:
Evaluation of anticoagulant behavior of thrombin-inhibiting polymer with fibrinolytic factor-binding sites and application for biomaterials
具有纤溶因子结合位点的凝血酶抑制聚合物的抗凝行为评价及其在生物材料中的应用
  • 批准号:
    14580840
  • 财政年份:
    2002
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AnaIysis of dynamic behavior of ribonuclease upon ligand binding using high resolution NMR
使用高分辨率 NMR 分析配体结合时核糖核酸酶的动态行为
  • 批准号:
    12672088
  • 财政年份:
    2000
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Shear Resisting Behavior of Reinforced Concrete Columns Under Biaxial Binding-Shear and Varying Axial Load
双轴绑剪和变轴荷载作用下钢筋混凝土柱的抗剪性能
  • 批准号:
    63460169
  • 财政年份:
    1988
  • 资助金额:
    $ 18.74万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了